Lumida
/NTLA
⌘K
Intellia Therapeutics Inc

Intellia Therapeutics Inc

NTLA
$11.74USD↓-1.59%-0.19 today

MARKET CAP

1.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$12 – $12

52W RANGE

$8
$28

AI Summary

Stalk
Sell NowMedium

NTLA remains entrenched in a pronounced downtrend, with price trading well below its major moving averages and having broken key support. Stage 4 distribution and bearish EMA alignment confirm medium-term skew to the downside, while short-term weakness and failed rallies into the 9/20 EMA and 50 SMA zones align timing for immediate downside participation. Execution is recommended now on any bounce toward those resistance areas for rejection and continuation.

  • ↑Lombosi Phase 3 data showed an 87% reduction in mean monthly attacks, with 62% of patients attack-free
  • ↑Intellia held $628.4M cash as of Q2 2026, supporting R&D into at least 2028
  • ↓Q2 2026 net loss was $106.6M, up from $101.3M year-over-year
Full analysis →

Buying

10

institutions

Selling

6

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY15.41 M260.72 M+3.25 M+67.3%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

BUYNEW4.53 M76.60 M+4.53 M+0.0%0.67%
VI

Voloridge Investment Management, LLC

Q2 2026

BUY2.07 M34.96 M+454.82 K+69.2%0.15%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW1.40 M23.69 M+1.40 M+0.0%0.03%
WP

Woodline Partners LP

Q2 2026

BUY1.08 M18.19 M+673.35 K+253.1%0.06%
CA

Citadel Advisors LLC

Q2 2026

SELL788.81 K13.35 M+-328.83 K-6.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY542.16 K9.17 M+245.15 K+140.9%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL527.66 K8.87 M+-20.83 K+38.8%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL492.95 K8.34 M+-137.57 K+3.2%0.00%
MM

Millennium Management LLC

Q2 2026

BUY491.23 K8.31 M+420.67 K+818.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY141.89 K2.40 M+367.00+32.3%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY77.95 K1.32 M+4.03 K+39.2%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY95.91 K1.23 M+47.96 K+185.3%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-169.29 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-53.80 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-19.52 K-100.0%0.00%